Method for treating multiple sclerosis
US5112810A · kind A · utility
27Cited by
2References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 15, 1985 |
| Grant date | May 12, 1992 |
| Priority date | — |
| Expiry date | May 15, 2005 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A pharmaceutical composition containing serum thymic factor (FTS) and a method for using FTS containing compositions for treating a variety of immunodeficiencies and autoimmune diseases including multiple sclerosis, Guillain-Barre syndrome, inflammatory neuropathy, polyneuritis and other immunodemyelinating diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.